Grail, Inc. GRAL
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Grail, Inc. is a biotechnology company headquartered in Menlo Park, California, founded in 2015. The company focuses on alleviating the global burden of cancer through innovative multi-cancer early detection technologies. Its flagship product, the Galleri test, is a blood-based liquid biopsy that screens for multiple d…
SectorHealthcare
ExchangeNASDAQ
IndustryDiagnostics & Research
CountryUnited States
Employees910
TickerGRAL
Statistics
Market Cap$2.44B
Revenue (TTM)$147.2M
Net Income-$408.4M
Net Margin-277.5%
EPS$-11.11
P/E-5.37
P/S16.64
P/B1.00
EV/EBITDA-4.83
ROE-16.1%
Dividend Yield—
Price$59.32
Data: Twelve Data · Revenue = mcap / P/S